The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - AstraZeneca; Astro Pharma; MSD; Novartis; Pfizer; Pierre Fabre; Roche
Travel, Accommodations, Expenses - AstraZeneca; Astro Pharma; MSD; Novartis; Pfizer; Pierre Fabre; Roche
Safety and clinical evaluation of dual inhibition with pertuzumab and trastuzumab in HER-2-positive breast cancer patients.
 
Christoph Suppan
Consulting or Advisory Role - Lilly; Novartis; Pfizer; Roche
Speakers' Bureau - Lilly; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Lilly; Novartis; Pfizer; Pierre Fabre; Roche
 
Daniel Steiner
No Relationships to Disclose
 
Valentina Eva Klocker
Travel, Accommodations, Expenses - Pierre Fabre
 
Florian Posch
Consulting or Advisory Role - Daiichi Sankyo; Pfizer
Speakers' Bureau - Daiichi Sankyo
 
Elisabeth Christina Henzinger
No Relationships to Disclose
 
Herbert Stoeger
No Relationships to Disclose
 
Nadia Dandachi
No Relationships to Disclose
 
Marija Balic
Consulting or Advisory Role - Amgen; AstraZeneca; Lilly; MSD; Novartis; Pfizer; Pierre Fabre; Roche
Speakers' Bureau - Amgen; AstraZeneca; Lilly; MSD; Novartis; Pfizer; Pierre Fabre; Roche
Research Funding - Lilly; Novartis; Pfizer; Samsung
Travel, Accommodations, Expenses - AstraZeneca; Lilly; MSD; Pfizer; Roche